Penumbra, Inc. Share Price
NYSE: PEN | Large CapPenumbra, Inc. Stock Performance
Open $325.70 | Prev. Close $324.63 | Circuit Range N/A |
Day Range $325.27 - $326.37 | Year Range $221.33 - $362.39 | Volume 9,713 |
Average Traded $326.06 |
Penumbra, Inc. Share Price Today
As of 11 August 2026, Penumbra, Inc.'s share price is $326.03. The stock opened at $325.70, compared to its previous close of $324.63. During today's trading session, Penumbra, Inc.'s share price traded between $325.27 and $326.37, with an average price of $325.82. Over the past 52 weeks, the stock has recorded a high of $362.39 and a low of $221.33. In terms of performance, Penumbra, Inc.'s share price has declined by 5.32% over the last six months and is up 19.44% on a year-on-year basis.
Penumbra, Inc. Share Price Chart
Penumbra, Inc. Stock Fundamentals & Key Indicators
Market Cap $12.69B | PE Ratio (TTM) 71.34 | Dividend Yield N/A |
EPS (TTM) $4.57 | Revenue (TTM) $1.40B | Return On Equity (TTM) 12.45% |
Profit Margin 12.66% | Debt to Equity 0.13 | Quarterly Earnings Growth YoY 55.28% |
Penumbra, Inc. Quarterly Profit & Loss
All figures in USD
Penumbra, Inc. Annual Profit & Loss
All figures in USD
About Penumbra, Inc.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Penumbra, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $322.12 | $324.57 | +1.08% |
Jul 2026 | $317.10 | $321.11 | +1.78% |
Jun 2026 | $318.86 | $315.50 | -0.87% |
May 2026 | $326.22 | $318.27 | -2.49% |
Apr 2026 | $329.01 | $326.40 | -0.53% |
Mar 2026 | $342.51 | $328.14 | -4.70% |
Feb 2026 | $358.82 | $344.34 | -3.91% |
Jan 2026 | $310.10 | $358.34 | +15.10% |
Dec 2025 | $294.02 | $311.34 | +6.28% |
Nov 2025 | $224.74 | $292.95 | +28.93% |
Oct 2025 | $254.79 | $227.22 | -10.32% |
Sep 2025 | $273.35 | $253.37 | -7.18% |